Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism?

Claudine Tardy1, Nathalie Andrieu-Abadie, Robert Salvayre

  • 1INSERM U.466, Laboratoire de Biochimie, CHU Rangueil, Toulouse, France.

Insights

Lysosomal storage disorders involve genetic defects affecting cell function. This review explores how programmed cell death (apoptosis) contributes to disease development, especially in neurological conditions.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Lysosomal storage disorders (LSDs) stem from genetic defects in lysosomal enzymes or proteins.
  • Despite gene identification, the precise molecular mechanisms driving LSD pathophysiology remain unclear.
  • Cellular and tissue damage in LSDs, particularly neurological ones, requires further investigation.

Purpose of the Study:

  • To review the potential role of apoptotic cell death in LSD pathogenesis.
  • To examine the link between apoptosis and cellular/tissue lesions in LSDs, with a focus on neurological manifestations.
  • To discuss the controversial involvement of sphingolipids and cathepsins in regulating apoptosis in LSDs.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of observations on altered apoptosis induction in LSDs.
  • Discussion of molecular regulators of apoptosis, including sphingolipids and cathepsins.

Main Results:

  • Evidence suggests a complex, often contradictory, role for apoptosis in LSD development.
  • Apoptosis can be either decreased or exacerbated in various LSD contexts.
  • Sphingolipids and cathepsins are implicated, though controversially, in modulating apoptotic pathways in LSDs.

Conclusions:

  • Apoptotic cell death is a significant factor in the pathophysiology of lysosomal storage disorders.
  • Understanding the regulation of apoptosis is crucial for elucidating LSD mechanisms, especially in the nervous system.
  • Further research is needed to clarify the precise roles of specific molecules like sphingolipids and cathepsins in LSD-associated apoptosis.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...